|
авторы:
|
Список литературы 1. Shah D., Darling С, Chang В. et al. Long-Term Results of In Situ Saphenous Vein Bypass Analysis of 2058 Cases. Annals of surgery.1995; 222 (4): 438-448. 2. Shapiro S. Meta-analysis / Shmeta-analysisPoint. Am.J. Epidemiоl. 1994; 140: 771-778. 3. Mamode N., Scott R.N. Graft type for femoropopliteal bypass surgery. Cochrane. Database.Syst. Rev. 2000; 2: CD 001487. 4. Klinkert P., Post P. N., Breslau P. J., van BockelJ. H. Saphenous vein versus PTFE for above knee femoropopliteal bypass. A review of the literature. Eur. J. Vasc. Endovasc. Surg. 2004;27 (4): 357-362. 5. Lawson J. A., Tangelder M. J., Algra A.,Eikelboom B.C. The myth of the in situ graft:superiority in infrainguinal bypass surgery?Eur. J. Vasc. Endovasc. Surg. 1999; 18 (2):149-157. 6. Abbott W.M., Green R.M., Matsumoto T. et al.Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group.J. Vasc. Surg. 1998; 27 (1):191-192. 7. Post S., Kraus T, Muller-Reinartz U. et al.Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur. J. Vasc.Endovasc. Surg. 2001; 22 (3): 226-231. 8. Vroegindeweij D., Vos L.D., Tielbeek A.V. et al. Balloon angioplasty combined with primary stenting versus balloon angioplastyalone in femoropopliteal obstructions. A comparative randomized study. Cardiovasc.Intervent. Radiol. 1997; 20: 420-425. 9. Zdanowski Z., Albrechtsson U., Lundin A. Et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.Int. Angiol. 1999; 18: 251-255. 10. Cejna M., Thurnher S., liasch H. et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J. Vasc. Interv.Radiol. 2001; 12: 23-31. 11. Grenacher L., Saam T., Geier A. et al. РТА versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA). Rofo. 2004; 176: 1302-1310. 12. Grimm J., Muller-Hulsbeck S., Jahnke T. et al.Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J. Vasc. Interv. Radiol. 2001;12: 935-942. 13. Becquemin J.P., Favre J.P., Marzelle J. et al.Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study.J. Vasc. Surg. 2003; 37: 487-494. 14. Schillinger M., Sabeti S., Dick P. et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.Circulation. 2007; 115 (21): 2745-2749. 15. Krankenberg H., Schluter M., Steinkamp H.et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superfcial femoral artery lesions up to 10 cm in length:the femoral artery stenting trial (FAST).Circulation. 2007; 116 (3): 285?292. 16. Wilson S.E., Wolf G.L., Cross A.P.Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis:report of a prospective randomized trial in a selected group of patients. / Vase. Surg. 1989;9: 1-9. 17. Holm J., Arfvidsson B., Jivegard L. et al.Chronic lower limb ischaemia: a prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur. J.Vasc. Surg. 1991; 5: 517-522. 18. Van der Zaag E.S., Legemate D.A., Prins M.H. et al. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur. J. Vasc. Endovasc. Surg. 2004;28: 132-137. 19. Adam D.J., Beard J.D., Cleveland T. et al.BASIL trial participants. The Lancet. 2005; 366(9501): 1905-1912. 20. Kedora J., Hohmann S., Garrett W. et al.Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoralpopliteal bypass in the treatment of superficial femoral arterial occlusive disease.J. Vasc.Surg. 2007; 45 (1): 10-16. 21. Eikelboom B.C. Aspirin versus Warfarin after Lower Extremity Bypass: Is the Incidence of Bypass Failure Different? Results of a Randomized Trial.J. Vasc. Surg. 2001; 34 (2):254-262. 22. Watson H.R., Skene A.M., Belcher G. Graftmaterial and results of platelet inhibitor trials in peripheral arterial reconstructions: reappraisal of results from a meta-analysis. Blackwell Science Ltd. Br. J. Clin. Pharmacol. 2000;49: 479-483. 23. Pokrajac B., Potter R., Maca T. et al. Intraarterial (192) Ir high-dose-rate brachytherapy for prophylaxis of restenosisafter femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int. J. Radiat. Oncol.ol. Phys. 2000; 48 (4): 923-931. 24. Minar E., Pokrajac B., Maca T. et al.Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study.Circulation. 2000; 102: 2694-2699. 25. Minar E., Pokrajac B., Ahmadi R. et al.Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology. 1998; 208:173-179. 26. Pokrajac B., Potter R., Wolfram R.M. et al.Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother. Oncol. 2005; 74: 3-9. 27. Wolfram R.M., Budinsky A.C., Pokrajac B. et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up - prospective randomized study. Radiology. 2006; 240: 878-884. 28. Wolfram R.M., Budinsky A.C., Pokrajac B. et al. Vascular brachytherapy with 192 Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up resul-from the Vienna-5 trial. Radiology. 2005; 236: 343-351. 29. Gallino A., Do D.D., Alerci M. et al. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. J. Endovasc. Ther. 2004; 11 (6): 595-604.
